Study ID: TAL-MB-100

Study Title

A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

Teva Identifier

TAL-MB-100

ClinicalTrials.gov Identifier

NCT00868361

Study Status

Terminated

Trial Condition(s)

Healthy

Interventions

Drug: Talampanel (non-radiolabeled), [14C] Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
disease icon for clinical trials

Key Participation Requirements

Gender

Male

Age Range

18 Years to 55 Years

Trial Duration

05/01/2009 - 09/01/2009

Phase

Phase 1

Study Type

Interventional